Thursday 15 March 2018

Lysosomal Storage Disease (LSD) Market : Trends & Opportunities (2018-2023) - New Report by Orbis Research


Latest Report Available at Orbis research Lysosomal Storage Disease (LSD) Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Request sample copy of this report @ http://orbisresearch.com/contacts/request-sample/2099758  .

Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. 
A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.

The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy. However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.

The report “Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook.

Browse Complete Report @ http://orbisresearch.com/reports/index/global-lysosomal-storage-disease-lsd-market-fabry-gaucher-and-pompe-industry-analysis-and-outlook-2018-2022 .

The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the global market. The report profiles the key players of the market including Pfizer Inc., Sanofi S.A., Shire Plc and Protalix BioTherapeutics, Inc.

Some points From TOC:

  1. Market Overview
    1.1 Lysosomal Storage Disease (LSD)
    1.2 Classification of LSD
    1.3 Symptoms
    1.4 Diagnosis
    1.5 Treatment
    1.6 Upcoming Treatment
  2. Global LSD Market Analysis
    2.1 Global LSD Market Forecast by Value
    2.2 Global LSD Market Value by Category
    2.3 Global Fabry Disease Market Forecast by Value
    2.4 Global Fabry Disease Market Value by Drugs 
    2.4.1 Global Fabrazyme Sales Value
    2.4.2 Global Replagal Sales Value
    2.4.3 Global Galafold Sales Value
    2.5 Global Gaucher Disease Market Forecast by Value
    2.6 Global Gaucher Disease Market Value by Drugs
    2.6.1 Global Cerezyme Sales Value
    2.6.2 Global Vipriv Sales Value
    2.6.3 Global Cerdelga Sales Value
    2.7 Global Pompe Disease Market Forecast by Value
    2.8 Global Pompe Disease Market Value by Drugs
    2.8.1 Global Myozyme Sales Value

Purchase a copy of Lysosomal Storage Disease (LSD) Market visit @ http://orbisresearch.com/contact/purchase/2099758   For more information contact sales@orbisresearch.com        

  1. Market Dynamics
    3.1 Growth Drivers
    3.1.1 Growing Ashkenazi (Eastern and Western Europe) Population
    3.1.2 Rising Pharmaceutical R&D Spending
    3.1.3 Increasing Disposable Income
    3.1.4 Growing Healthcare Expenditure
    3.1.5 Accelerating Economic Growth
    3.2 Key Trends & Developments
    3.2.1 Progressing Drugs under Pipeline
    3.2.2 Increasing Preference towards Gene Therapy
    3.3 Challenges
    3.3.1 Stringent Regulations
    3.3.2 Limited Access to Patent Rights
  2. Competitive Landscape
    4.1 Global Market
    4.1.1 Revenue Comparison of Key Players
    4.1.2 Market Cap Comparison of Key Players
    4.1.3 Global LSD Market-Annual Treatment Cost Comparison by Company

 For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

No comments:

Post a Comment